Target intelligence / Profile preview

Negative regulator of antiviral response (non-protein coding) (NRAV)

Target
NRAV
Molecular classification
Long non-coding RNA, Other
01

Overview

Negative regulator of antiviral response (NRAV) is a long non-coding RNA gene located on chromosome 12 (12q24.31), also referred to as DYNLL1-AS1 or DYNLL1 antisense RNA 1[7][6]. NRAV acts as a key negative modulator of the antiviral innate immune response, particularly by suppressing the transcription of multiple interferon-stimulated genes (ISGs) critical for defense against viral infection (e.g., IFITM3, MxA)[2]. During infection with various RNA and DNA viruses, NRAV levels are rapidly downregulated as part of the host's antiviral defense, and its ectopic overexpression promotes viral replication and impairs defense[2][5]. Mechanistically, NRAV influences antiviral gene expression by affecting histone modification at ISG promoters. While NRAV is not a receptor, enzyme, or traditional 'druggable' protein, it is viewed as a potential therapeutic target due to its prominent modulatory role in host–virus interactions and immune regulation[2][3][5].

Other names
DYNLL1-AS1DYNLL1AS1DYNLL1 antisense RNA 1
02

Mechanism of action

Negative regulation of initial transcription of critical interferon-stimulated genes (e.g., IFITM3, MxA) via modulation of histone modification[2]

03

Biological functions

Negative regulation of interferon-stimulated gene expressionModulation of antiviral innate immune responseRegulation of histone modification at ISG promoters
04

Disease associations

Infection (regulation of host antiviral response; implicated in promotive effect on viral replication, e.g., Influenza A)Other (potential for involvement in host–pathogen interactions and immune homeostasis)
05

Safety considerations

Therapeutic suppression of NRAV expression could enhance antiviral defense but may risk excessive immune activation or cytokine-induced tissue damage[2][3]

Beyond the preview

Go deeper on Negative regulator of antiviral response (non-protein coding) (NRAV).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Negative regulator of antiviral response (non-protein coding) (NRAV).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call